The company is developing an intramedullary limb lengthening nail to treat leg length discrepancies or to address non-unions after failed fracture treatments or tumors. Intramedullary limb lengthening devices still represent a portfolio gap for most of the global players in the orthopedic and spine industry. The investment in Prolixo is coordinated in alignment with SHS V portfolio company Blue Ocean Spine.
Investors 1
| Date | Name | Website |
| 12.05.2021 | SHS Gesell... | shs-capita... |